Edition:
United Kingdom

NanJing Pharmaceutical Co Ltd (600713.SS)

600713.SS on Shanghai Stock Exchange

6.43CNY
6:27am GMT
Change (% chg)

¥0.13 (+2.06%)
Prev Close
¥6.30
Open
¥6.33
Day's High
¥6.45
Day's Low
¥6.33
Volume
4,617,326
Avg. Vol
4,068,823
52-wk High
¥8.45
52-wk Low
¥6.13

Latest Key Developments (Source: Significant Developments)

Nanjing Pharmaceutical and unit plan two PBM project JVs
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Nanjing Pharmaceutical Co Ltd <600713.SS>:Says it will invest 2 million yuan to set up a Jiangsu-based PBM (medical benefit management)business JV and hold 40 percent stake in the JV after transaction .Says Nanjing-based pharmaceutical unit will invest 3 million yuan to set up a Nanjing-based PBM related pharmacy JV and hold 60 percent stake in the JV after transaction .  Full Article

NanJing Pharmaceutical to set up two units and two branches for regional network construction
Friday, 24 Nov 2017 

Nov 24 (Reuters) - NanJing Pharmaceutical Co Ltd <600713.SS> ::Says it plans to use 30 million yuan to set up wholly owned Changzhou unit and 20 million yuan to set up wholly owned Taizhou unit as well as two branches in Zhenjiang and Lianyungang for regional distribution network construction.  Full Article

NanJing Pharmaceutical unit to set up smart elder care center in Hefei
Monday, 30 Oct 2017 

Oct 30(Reuters) - NanJing Pharmaceutical Co Ltd <600713.SS>:Says co's Anhui-based unit and Anhui-based hospital will jointly invest 60 million yuan to set up smart elder care center firm in Hefei .  Full Article

NanJing Pharmaceutical acquires stake in three medicine related firms
Monday, 30 Oct 2017 

Oct 30(Reuters) - NanJing Pharmaceutical Co Ltd <600713.SS>:Says it acquired 20 percent stake in Jiang Su Hua Xiao Pharmal Euhcal Lugisinls Co Ltd.Says it acquired 20 percent stake in Nanjing Pharmaceurical Nantong Kambridge Co Ltd.Says it acquired 39.8 percent stake in Nanjing Pharmaceurical (Huaian) Tianyi Ltd.Says it fully acquired the three firms .  Full Article

NanJing Pharmaceutical signs cooperation agreement on pharmacy benefit management project
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - NanJing Pharmaceutical Co Ltd <600713.SS>:Says it signed cooperation agreement with a community health service center of Nanjing on Oct. 24.Says two entities mainly cooperate on pharmacy benefit management project .  Full Article

Nanjing Pharmaceutical issues 2017 2nd tranche super short-term financing notes worth 600 mln yuan
Tuesday, 17 Oct 2017 

Oct 17(Reuters) - Nanjing Pharmaceutical Co Ltd <600713.SS> ::* Says it issued 2017 2nd tranche super short-term financing notes worth 600 million yuan with a term of 60 days and interest rate of 4.4 percent.  Full Article

Nanjing Pharmaceutical signs letter of intent on medical welfare management project
Monday, 9 Oct 2017 

Oct 9 (Reuters) - Nanjing Pharmaceutical Co Ltd <600713.SS> ::* Says it signed letter of intent with Wanhu Health, a PBM company, to cooperate on medical welfare management project related business through technology JV and Welfare Management Center for patients with chronic diseases.  Full Article

Nanjing Pharmaceutical issues 300 mln yuan commercial paper
Monday, 22 Aug 2016 

Nanjing Pharmaceutical Co Ltd <600713.SS>: Says it issued 300 million yuan commercial paper with interest rate at 3 percent .Says the term of the commercial paper is 270 days.  Full Article

Nanjing Pharmaceutical to merge with pharmaceutical services unit
Monday, 1 Aug 2016 

Nanjing Pharmaceutical Co Ltd <600713.SS> : Says it plans to merge with its wholly owned Nanjing-based pharmaceutical services unit .Says unit will be dissolved after the transaction.  Full Article

Nanjing Pharmaceutical issues 100 mln yuan debt financing instruments
Monday, 25 Jul 2016 

Nanjing Pharmaceutical Co., Ltd. <600713.SS>: Says it completes 2016 first tranche private debt financing instruments worth 100 million yuan .Says the instruments with a term of three months and rate of 3.8 percent.  Full Article

BRIEF-Nanjing Pharmaceutical and unit plan two PBM project JVs

* Says it will invest 2 million yuan to set up a Jiangsu-based PBM (medical benefit management)business JV and hold 40 percent stake in the JV after transaction